Skip to main content
PharmGen Science, Inc. logo

PharmGen Science, Inc. — Investor Relations & Filings

Ticker · 004720 ISIN · KR7004720009 KO Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2020-06-08 Major Shareholding Noti…
Country KR South Korea
Listing KO 004720

About PharmGen Science, Inc.

http://www.pharmgenscience.com/en/

PharmGen Science, Inc. is a pharmaceutical company engaged in the research, development, production, and sale of medicaments. The company's portfolio encompasses a range of prescription (ETC) and over-the-counter (OTC) drugs, including analgesics, antibiotics, and anti-inflammatory agents. A key strategic focus for the company is the discovery and development of novel drugs for gastrointestinal (GI) disorders. PharmGen Science aims to provide integrated pharmaceutical solutions by leveraging its diverse infrastructure and global network.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when an entity or individual acquires a significant stake (typically 5% or more) in a listed company. This document details the shareholding of 'HD Investment Association' in 'Wooridul Pharmaceutical', including the purpose of holding, changes in share ownership, and funding sources. Since this is a specific regulatory disclosure regarding major shareholding thresholds, it falls under the 'Major Shareholding Notification' category.
2020-06-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used by executives and major shareholders to report changes in their shareholdings in a listed company (in this case, Wooridul Pharmaceutical). This type of filing is classified as a Director's Dealing (DIRS) as it reports personal share transactions by major shareholders/insiders.
2020-06-08 Korean
최대주주등소유주식변동신고서(최대주주변경시)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서), which is a standard regulatory filing in South Korea (DART system) used to disclose changes in ownership by major shareholders and related parties. This specific filing details the change in the largest shareholder from an individual (Kim Soo-kyung) to an investment entity (HD Investment Association). This falls under the category of Major Shareholding Notification as it tracks the movement of significant ownership stakes.
2020-06-08 Korean
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a change in the company's largest shareholder (maximum shareholder). It details the transfer of shares from the previous shareholder (Kim Soo-kyung) to the new shareholder (HD Investment Association) for the purpose of management participation. Since this is a specific regulatory disclosure regarding ownership structure changes that does not fit into the other specific categories like 'Major Shareholding Notification' (which usually refers to 5% rule filings) or 'Director's Dealing', it is best classified as a general Regulatory Filing (RNS).
2020-06-08 Korean
투자판단관련주요경영사항
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (Woori-dle Pharmaceutical) announcing a change in the largest shareholder due to a stock transfer agreement. This type of disclosure regarding changes in ownership structure and major management/shareholder shifts is classified as a regulatory filing (RNS) as it does not fit into specific categories like M&A (which usually implies corporate mergers/acquisitions of entities) or Major Shareholding Notification (which typically refers to institutional investors reporting their holdings). Given the nature of the disclosure as a 'major management matter' (주요경영사항), RNS is the most appropriate classification.
2020-06-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when company insiders (executives or major shareholders) trade company stock. This falls under the category of Director's Dealing (insider trading/shareholding changes).
2020-05-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.